Rhythm Biosciences Limited

A$0.07As of Sun 8 Nov 2026, 12:00 UTC
ASX:RHYHealthcare
Country Australia
PE (Fwd) •••
TSR 9Y CAGR (13.10%)
Div yield —
ROE (276.00%)
Diagnostics & Research
Beta (5Y) 0.66
PE TTM —
TSR TTM (25.00%)
Mkt cap A$24.42M
ROIC (129.49%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0783
13.50%
(67.19%)
Hold 8|7|8|5|3
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
2.72%
(4.55%)
9.20%
3.63%
Revenue$M
1.207
1.259
1.315
1.349
10.56%
10.35%
17.92%
15.02%
Peers (US$16.77M)
Cap (US$)
PE
12.89M
99.65x
16.27M
—
Capital
TTM
5Y
10Y
Leveragex
1.119
0.036
0.035
EBIT/Intx
1.424
2.013
1.630
Own earn%
225.40
(57.32)
(29.30)
Sh yield%
35.49
33.35
32.98
Owners
Insiders/Inst%
13.51
53.56
Short interest%
2.93
SBC / revenue%
5.78
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
10–19
$1 testx
—
Incr. ROIC%
39